"МБАЛ Доверие е модерен медицински комплекс, разделен функционално на диагностично-консултативен център и многопрофилна болница за активно лечение. Болница Доверие е една от първите частни болници в България. Създадена е в края на 2005 г. и вече над 10 години е част от „Доверие Обединен холдинг” АД. Тя е модерна, европейска болница, различна от стандартните български болници във всяко отношение, като предлага много по-съвременно обслужване, апаратура и леглова база. На разположение на пациентите на МБАЛ Доверие са: - Медицински център, разполагащ със собствени лаборатории и високотехнологично диагностично оборудване - 9 специализирани отделения за болнична помощ - 4 операционни зали и стационар от над 100 легла"

During the past decade, MHAT Doverie AD conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "MHAT Doverie AD" are "Crohn Disease" (1 trials), "Crohn's Disease" (1 trials), "Depression" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Plaque Psoriasis" (1 trials). Many other conditions were trialed in "MHAT Doverie AD" in a lesser frequency.

Most popular intervention types in "MHAT Doverie AD" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "GED-0301" (2 trials), "Armodafinil" (1 trials), "CF101" (1 trials) and "PF-06882961" (1 trials). Other intervention names were less common.

The vast majority of trials in "MHAT Doverie AD" are 5 trials for "All" genders.

Currently, there are NaN active trials in "MHAT Doverie AD". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in MHAT Doverie AD, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in MHAT Doverie AD, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".